Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
51°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Renovorx Inc
(NQ:
RNXT
)
1.210
UNCHANGED
Streaming Delayed Price
Updated: 3:08 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,637
Open
1.230
Bid (Size)
1.160 (10)
Ask (Size)
1.170 (2)
Prev. Close
1.210
Today's Range
1.140 - 1.246
52wk Range
0.5306 - 3.290
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement
April 18, 2024
From
RenovoRx , Inc.
Via
Business Wire
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
April 16, 2024
From
RenovoRx, Inc.
Via
Business Wire
Performance
YTD
-38.89%
-38.89%
1 Month
-8.33%
-8.33%
3 Month
-19.33%
-19.33%
6 Month
+14.15%
+14.15%
1 Year
-59.26%
-59.26%
More News
Read More
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026
April 15, 2024
From
RenovoRx, Inc.
Via
Business Wire
RNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023
April 08, 2024
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 09, 2024
Via
InvestorPlace
RenovoRx Announces $11.1 Million at Market Private Placement
April 08, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024
April 05, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024
March 12, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Highlights Key Leadership Promotions
March 08, 2024
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx CEO Issues Letter to Shareholders
February 06, 2024
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 31, 2024
Via
Benzinga
RenovoRx Closes $6.1 Million Private Placement
January 29, 2024
From
RenovoRx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 02, 2024
Via
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 29, 2023
Via
Benzinga
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 28, 2023
Via
Benzinga
Clinical Trials at Major University; New Application Targeting Tumors with an IP Portfolio of 9 Patents Issued, 9 Pending for Cancer Treatments Partnered with Imugene: RenovoRx (NASDAQ: RNXT)
December 28, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
RenovoRx (NASDAQ: RNXT) Elevates IP Portfolio with New Application and Advances Cancer Treatments in Phase 3 Clinical Trials
December 21, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
December 21, 2023
From
RenovoRx, Inc.
Via
Business Wire
RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
December 19, 2023
From
RenovoRx, Inc.
Via
Business Wire
Biopharma Company Issues New Patent Application Adding to Strong IP Portfolio of 9 Patents Issued and 9 Pending; Phase 3 Clinical Trials for Cancer Treatments in Collaboration with Imugene: RenovoRx (NASDAQ: RNXT) $RNXT
December 19, 2023
Via
Viz Release
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 14, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.